Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Aimovig
Aimovig
Express Scripts covers Amgen, Lilly migraine therapies, excludes Teva drug
Yahoo/Reuters
Wed, 10/17/18 - 09:22 am
Express Scripts
PBMs
migraines
Eli Lilly
Amgen
Teva Pharmaceutical
Emgality
Aimovig
Ajovy
Three new drugs will compete fiercely to revolutionize migraine treatment — with identical $6,900 price tags
Marketwatch
Fri, 09/28/18 - 12:32 pm
migraines
Eli Lilly
Emgality
Teva Pharmaceutical
Ajovy
Amgen
Novartis
Aimovig
Aimovig launch bolsters hopes for blockbuster sales
Biopharma Dive
Tue, 08/21/18 - 10:06 am
Aimovig
Amgen
Novartis
migraines
Amgen's new migraine drug hits insurance hurdles
Reuters
Thu, 07/26/18 - 07:41 pm
Amgen
migraines
Aimovig
insurers
Amgen, Novartis 'overwhelmed' by early interest in migraine drug Aimovig: expert
Fierce Pharma
Wed, 07/4/18 - 10:01 am
migraines
Amgen
Novartis
Aimovig
Migraine Breakthrough: Not So Fast
Forbes
Wed, 06/6/18 - 09:49 pm
Amgen
Novartis
Aimovig
migraines
adults
monoclonal antibodies
Thanks to lower-than-expected price, ICER backs Amgen's Aimovig—but only after other meds fail
Fierce Pharma
Fri, 06/1/18 - 11:40 am
Amgen
ICER
Aimovig
migraines
Will Amgen’s migraine win and 5th thumbs-up for Prolia drive enough growth? Nope, says analyst
Fierce Pharma
Tue, 05/22/18 - 06:06 pm
Amgen
FDA
Aimovig
migraines
Prolia
Migraine prevention drug could be worth $1 to $2 billion over next five years: Wall Street analyst
CNBC
Sat, 05/19/18 - 11:30 am
migraines
Amgen
Novartis
Aimovig
Amgen’s new migraine drug will cost 30 percent less than Wall Street expected
Stat
Thu, 05/17/18 - 09:48 pm
Amgen
Novartis
migraines
Aimovig
drug pricing
Amgen's Aimovig won its first-in-class migraine nod. Will payers step up to the $6,900 price?
Fierce Pharma
Thu, 05/17/18 - 09:42 pm
Amgen
Novartis
Aimovig
FDA
migraines
12 blockbusters: The surging list of $1B-plus drugs rolling out on the market this year might surprise you
Endpoints
Thu, 03/22/18 - 09:21 am
drug launches
Hemlibra
Roche
Biktarvy
Gilead Sciences
Ozempic
Novo Nordisk
Erleada
JNJ
Shingrix
GSK
Patisiran
Alnylam
Sanofi
Epidiolex
GW Pharma
Aimovig
Amgen
Novartis
lanadelumab
Shire
Elagolix
AbbVie
Steglatro
Pfizer
Merck
Sublocade
Indivior
Novartis Expects FDA and EMA Approvals for Aimovig in 2018
Yahoo/Market Realist
Wed, 02/21/18 - 09:47 am
Novartis
FDA
EMA
drug approvals
Aimovig
migraines
Amgen pulls ahead in sprint towards CGRP approval with promising PhIII migraine data
Endpoints
Wed, 11/29/17 - 09:44 pm
Amgen
CGRP blockers
migraines
Aimovig
erenumab
Amgen and Novartis ID the finish line in a wicked scramble for first CGRP migraine drug OK
Endpoints
Thu, 07/20/17 - 11:34 pm
Amgen
Novartis
migraines
CGRPs
Aimovig
Pages
« first
‹ previous
1
2